Clinical Trials Directory

Trials / Completed

CompletedNCT02530749

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

Status
Completed
Phase
Study type
Observational
Enrollment
265 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Frailty as an adjunct to preoperative assessment of neurosurgical patients has never been evaluated. This study aims to determine if frailty predicts neurosurgical complications in brain tumor patients and enhances current perioperative risk models.

Detailed description

Preoperative risk assessment is important, but inexact, in older patients because physiologic reserves are difficult to measure. This also makes an important difference related to brain tumor patients, who may be burdened with systemic disease, alterations in cognition, or affected by other comorbidities. When assessing quality of life for brain tumor patients, having a better predictor of postsurgical outcome would be beneficial in appropriately counseling these patients. Frailty is thought to estimate physiologic reserves, and its use has been found to predict postoperative complications, length of stay, and discharge to a skilled or assisted-living facility in neurosurgical patients. Frailty as an adjunct to preoperative assessment of neurosurgical patients has never been evaluated. This study aims to determine if frailty predicts neurosurgical complications in brain tumor patients and enhances current perioperative risk models.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2018-12-01
Completion
2019-03-01
First posted
2015-08-21
Last updated
2019-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02530749. Inclusion in this directory is not an endorsement.